CI&T Inc. Form 6-K Summary
Business Context and Reporting Period
Company: CI&T Inc. (NYSE: CINT), a global digital specialist providing end-to-end digital transformation services.
Reporting Period: Third Quarter (3Q) and Nine Months (9M) ended September 30, 2021.
Key Event: The company completed its Initial Public Offering (IPO) on November 15, 2021, raising net proceeds of US$156.7 million. The financial results include the consolidation of the Dextra acquisition, which closed on August 10, 2021.
Key Financial Metrics (3Q21)
| Metric | 3Q21 (R$) | 3Q20 (R$) | YoY Change |
|---|---|---|---|
| Net Revenue | 376.0 million | 242.9 million | +55% (+57% constant currency) |
| Adjusted EBITDA | 80.1 million | 65.2 million | +23% |
| Adjusted EBITDA Margin | 21.3% | 26.9% | -5.6 pts |
| Net Profit (Loss) | (2.2) million | 39.5 million | Turn to Loss |
| Adjusted Net Profit | 24.5 million | 39.9 million | -38% |
| Cash from Operations (9M) | 90.2 million | 102.7 million | -12% |
| Total Debt | 782.1 million | 89.2 million (Dec 2020) | Significant Increase |
| Net Debt | 668.7 million | N/A | N/A |
Note: All figures in Brazilian Reais (R$) unless otherwise noted. Net loss in 3Q21 was primarily driven by a non-cash impairment charge of R$21.8 million related to discontinued Dextra intangible assets.
Material Changes vs. Prior Period
- Revenue Growth: Driven by a 55% year-over-year increase, with 36% organic growth and 19% attributable to the Dextra acquisition. The U.S. market grew 44% YoY.
- Acquisition Impact: Consolidation of Dextra (closed Aug 10, 2021) added 1,167 employees and diversified the client base. Pro forma revenue for 3Q21 (assuming Jan 1 acquisition) was R$411.1 million.
- Cost Structure: Costs of services rose 64% YoY due to employee promotions and new hires. SG&A expenses increased 80% due to IPO-related costs, compliance staffing, and M&A expenses.
- Debt Profile: Total debt increased significantly to R$782.1 million, primarily due to R$650 million in new debt incurred to finance the Dextra acquisition (maturing 2026).
- Profitability: While Adjusted EBITDA grew, the margin compressed from 26.9% to 21.3% due to higher operating costs and financial expenses. Reported net profit turned to a loss due to the one-time impairment charge.
Guidance, Outlook, and Risks
- 4Q21 Guidance: Management expects net revenue of at least R$440.0 million, representing 66% growth YoY.
- Full Year 2021 Guidance: Pro forma net revenue expected to be at least R$1,600 million (38% growth YoY).
- Strategic Initiatives: Launched "Cognitive Lab" (C-Lab) with UNICAMP to develop machine learning tools for customer service automation.
- Risks:
- Integration Risk: Successful integration of Dextra is critical to realizing synergies.
- FX Exposure: Revenue is largely in foreign currencies while expenses are in BRL, creating exchange rate volatility.
- Debt Servicing: Increased leverage from the acquisition and IPO-related costs.
- Client Concentration: Top 10 clients represent 60% of revenue; top client represents 17%.
Investor Verification Checklist
- Debt Covenants: Verify compliance with loan covenants given the significant increase in leverage (R$782M debt vs. R$113M cash).
- Impairment Details: Confirm the non-recurring nature of the R$21.8M impairment on Dextra intangible assets and ensure no further write-downs are anticipated.
- Pro Forma Adjustments: Review the pro forma financials to understand the full impact of the Dextra acquisition on margins and earnings power.
- Client Concentration: Assess the risk associated with the top client contributing 17% of revenue and the top 10 contributing 60%.
- FX Hedging: Evaluate the effectiveness of the company's derivative instruments (NDFs, options) in mitigating currency risk.